WEE1 and rheumatoid arthritis: In this study, we introduced a novel multi-protein kinase inhibitor, KMU-11342, showcasing its potential in mitigating inflammation in various immune cells implicated in RA pathogenesis and in inhibiting osteoclastogenesis.